A new trading day began on January 23, 2023, with Agile Therapeutics Inc. (NASDAQ: AGRX) stock priced at $0.304, up 5.86% from the previous day of trading. During the day, the shares moved up to $0.304 and dropped to $0.28 before settling in for the closing price of $0.28. AGRX’s price has ranged from $0.17 to $15.60 over the past 52 weeks.
Meanwhile, its annual earnings per share averaged -26.00%. With a float of $36.81 million, this company’s outstanding shares have now reached $37.00 million.
The extent of productivity of a business whose workforce counts for 30 workers is very important to gauge. In terms of profitability, gross margin is -32.11, operating margin of -1731.41, and the pretax margin is -1826.24.
Agile Therapeutics Inc. (AGRX) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Agile Therapeutics Inc. is 0.20%, while institutional ownership is 5.70%. The most recent insider transaction that took place on Aug 26, was worth 22,500. In this transaction Chief Executive Officer of this company bought 50,000 shares at a rate of $0.45, taking the stock ownership to the 64,343 shares.
Agile Therapeutics Inc. (AGRX) Latest Financial update
In its latest quarterly report, released on 6/29/2022, the company reported earnings of -$2.71 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). This company achieved a net margin of -1826.24 while generating a return on equity of -255.62. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.27 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -26.00% per share during the next fiscal year.
Agile Therapeutics Inc. (NASDAQ: AGRX) Trading Performance Indicators
Here are Agile Therapeutics Inc.’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.20. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.44.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -14.93, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -0.67 in one year’s time.
Technical Analysis of Agile Therapeutics Inc. (AGRX)
The latest stats from [Agile Therapeutics Inc., AGRX] show that its last 5-days average volume of 0.78 million was inferior to 1.02 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 37.22%. Additionally, its Average True Range was 0.03.
During the past 100 days, Agile Therapeutics Inc.’s (AGRX) raw stochastic average was set at 47.98%, which indicates a significant decrease from 78.55% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 99.05% in the past 14 days, which was higher than the 95.95% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2228, while its 200-day Moving Average is $1.0332. Now, the first resistance to watch is $0.3069. This is followed by the second major resistance level at $0.3175. The third major resistance level sits at $0.3309. If the price goes on to break the first support level at $0.2829, it is likely to go to the next support level at $0.2695. The third support level lies at $0.2589 if the price breaches the second support level.
Agile Therapeutics Inc. (NASDAQ: AGRX) Key Stats
With a market capitalization of 12.07 million, the company has a total of 40,615K Shares Outstanding. Currently, annual sales are 4,100 K while annual income is -74,890 K. The company’s previous quarter sales were 3,000 K while its latest quarter income was -19,670 K.